GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.
GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.Expanding GE Healthcare's life science research and biopharmaceutical manufacturing contribution, the acquisition enhances a key area of growth for the company. A provider of cellular and protein science research technologies, as well as tools used in biopharmaceuticals' manufacture - products such as vaccines, cell therapies and antibodies - GE Healthcare will secure substantial customer benefits through the addition of Whatman's innovative filters and membranes for laboratory research, life sciences and medical technology applications.GE Healthcare's president and CEO of life sciences business commented: "Whatman's expertise and reputation on filtration technologies and sample preparation is a great fit for our life sciences business. We believe that combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical and drug discovery research."
LCGC’s Year in Review: Highlights in Liquid Chromatography
December 20th 2024This collection of technical articles, interviews, and news pieces delves into the latest innovations in LC methods, including advance in high performance liquid chromatography (HPLC), ultrahigh-pressure liquid chromatography (UHPLC), liquid chromatography–mass spectrometry (LC–MS), and multidimensional LC.
Next Generation Peak Fitting for Separations
December 11th 2024Separation scientists frequently encounter critical pairs that are difficult to separate in a complex mixture. To save time and expensive solvents, an effective alternative to conventional screening protocols or mathematical peak width reduction is called iterative curve fitting.